Relmada Therapeutics Inc (RLMD)

$ 4.03
   
  • Change Today:
    $0.22
  • 52 Week High: $4.83
  • 52 Week Low: $0.26
  • Currency: US Dollars
  • Volume: 254,008
  • RiskGrade: 274

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 n/a (47.10) (65.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-27 n/a (56.00) (69.50)¢ n/a n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

RLMD Market Data

Currency US Dollars
Share Price $ 4.03
Change Today $ 0.22
% Change 5.77 %
52 Week High $4.83
52 Week Low $0.26
Volume 254,008
RiskGrade 274

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 22-Jan-2026

Time Volume / Share Price
14:13 100 @ $4.03
14:13 100 @ $4.03
14:13 100 @ $4.03
14:13 300 @ $4.03
14:13 100 @ $4.03

Top of Page